JPH09165385A - キナゾリン誘導体 - Google Patents

キナゾリン誘導体

Info

Publication number
JPH09165385A
JPH09165385A JP6202018A JP20201894A JPH09165385A JP H09165385 A JPH09165385 A JP H09165385A JP 6202018 A JP6202018 A JP 6202018A JP 20201894 A JP20201894 A JP 20201894A JP H09165385 A JPH09165385 A JP H09165385A
Authority
JP
Japan
Prior art keywords
compound
substituted
lower alkyl
quinazolinyl
piperidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6202018A
Other languages
English (en)
Japanese (ja)
Inventor
Shigeki Fujiwara
繁喜 藤原
Yuko Okamura
祐子 岡村
Haruki Takai
春樹 高井
Hiromi Nonaka
裕美 野中
Takahiro Moriyama
孝広 森山
Kozo Yao
幸三 矢尾
Hiroshi Karasawa
啓 唐沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP6202018A priority Critical patent/JPH09165385A/ja
Priority to DE69519469T priority patent/DE69519469T2/de
Priority to EP95929231A priority patent/EP0726267B1/en
Priority to ES95929231T priority patent/ES2153491T3/es
Priority to CN95190792A priority patent/CN1043991C/zh
Priority to AU32655/95A priority patent/AU689304B2/en
Priority to AT95929231T priority patent/ATE197710T1/de
Priority to NZ291506A priority patent/NZ291506A/en
Priority to CA002174854A priority patent/CA2174854C/en
Priority to PCT/JP1995/001694 priority patent/WO1996006841A1/ja
Priority to JP8508612A priority patent/JP2810795B2/ja
Priority to KR1019960702161A priority patent/KR960705810A/ko
Priority to NO19961601A priority patent/NO310658B1/no
Priority to FI961758A priority patent/FI961758A0/fi
Publication of JPH09165385A publication Critical patent/JPH09165385A/ja
Priority to US09/089,255 priority patent/US5948784A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Luminescent Compositions (AREA)
  • Fireproofing Substances (AREA)
  • Furan Compounds (AREA)
JP6202018A 1994-08-26 1994-08-26 キナゾリン誘導体 Pending JPH09165385A (ja)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP6202018A JPH09165385A (ja) 1994-08-26 1994-08-26 キナゾリン誘導体
NZ291506A NZ291506A (en) 1994-08-26 1995-08-25 2-amino-4-(2,4-dioxotetrahydroquinazolin-3-yl(alkyl)- piperidin-1-yl)-quinazoline derivatives
CA002174854A CA2174854C (en) 1994-08-26 1995-08-25 Quinazoline derivative
ES95929231T ES2153491T3 (es) 1994-08-26 1995-08-25 Derivados de quinazolina.
CN95190792A CN1043991C (zh) 1994-08-26 1995-08-25 喹唑啉衍生物
AU32655/95A AU689304B2 (en) 1994-08-26 1995-08-25 Quinazoline derivative
AT95929231T ATE197710T1 (de) 1994-08-26 1995-08-25 Chinazolin-derivate
DE69519469T DE69519469T2 (de) 1994-08-26 1995-08-25 Chinazolin-derivate
EP95929231A EP0726267B1 (en) 1994-08-26 1995-08-25 Quinazoline derivatives
PCT/JP1995/001694 WO1996006841A1 (fr) 1994-08-26 1995-08-25 Derive de quinazoline
JP8508612A JP2810795B2 (ja) 1994-08-26 1995-08-25 キナゾリン誘導体
KR1019960702161A KR960705810A (ko) 1994-08-26 1995-08-25 퀴나졸린 유도체(quinazoline derivatives)
NO19961601A NO310658B1 (no) 1994-08-26 1996-04-22 Kinozolinderivater, farmasöytisk preparat inneholdende slike derivater, anvendelse derav, og fremgangsmåte for deresfremstilling
FI961758A FI961758A0 (fi) 1994-08-26 1996-04-24 Kinatsoliinijohdannainen
US09/089,255 US5948784A (en) 1994-08-26 1998-06-03 Quinazoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6202018A JPH09165385A (ja) 1994-08-26 1994-08-26 キナゾリン誘導体

Publications (1)

Publication Number Publication Date
JPH09165385A true JPH09165385A (ja) 1997-06-24

Family

ID=16450565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6202018A Pending JPH09165385A (ja) 1994-08-26 1994-08-26 キナゾリン誘導体

Country Status (14)

Country Link
US (1) US5948784A (es)
EP (1) EP0726267B1 (es)
JP (1) JPH09165385A (es)
KR (1) KR960705810A (es)
CN (1) CN1043991C (es)
AT (1) ATE197710T1 (es)
AU (1) AU689304B2 (es)
CA (1) CA2174854C (es)
DE (1) DE69519469T2 (es)
ES (1) ES2153491T3 (es)
FI (1) FI961758A0 (es)
NO (1) NO310658B1 (es)
NZ (1) NZ291506A (es)
WO (1) WO1996006841A1 (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999019326A1 (fr) * 1997-10-15 1999-04-22 Kyowa Hakko Kogyo Co., Ltd. Derives de piperidine
WO1999053924A1 (fr) * 1998-04-17 1999-10-28 Kyowa Hakko Kogyo Co., Ltd. Agent analgesique
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US6900221B1 (en) 1999-11-11 2005-05-31 Osi Pharmaceuticals, Inc. Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
ATE241985T1 (de) * 1996-02-19 2003-06-15 Kyowa Hakko Kogyo Kk Therapeutisches mittel zur behandlung von nierenerkrankungen
WO1998033792A1 (fr) * 1997-01-31 1998-08-06 Kyowa Hakko Kogyo Co., Ltd. Derives de la piperidine
US5866574A (en) * 1997-04-10 1999-02-02 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
EP1480980A4 (en) * 2002-02-15 2005-04-20 Cytokinetics Inc SYNTHESIS OF QUINAZOLINONES
WO2003094839A2 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
EP1553931A4 (en) 2002-05-09 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
AU2003290507A1 (en) * 2002-05-10 2004-04-08 Cytokinetics, Inc. Compounds, compositions and methods
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
AU2003236527A1 (en) * 2002-06-14 2003-12-31 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (en) * 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
WO2004034972A2 (en) * 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004052862A1 (ja) * 2002-12-10 2004-06-24 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途
EP1682534A2 (en) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions, and methods
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
EP2520567A3 (en) * 2006-02-23 2012-12-12 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
EP3028703B1 (en) 2013-07-29 2019-12-04 Kyowa Kirin Co., Ltd. Piperidine derivatives as wnt signaling inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583225A5 (es) * 1972-09-25 1976-12-31 Sandoz Ag
US5296487A (en) * 1990-01-02 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Quinazoline derivatives and their preparation
US5624926A (en) * 1993-02-18 1997-04-29 Kyowa Hakko Kogyo Co., Ltd. Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999019326A1 (fr) * 1997-10-15 1999-04-22 Kyowa Hakko Kogyo Co., Ltd. Derives de piperidine
WO1999053924A1 (fr) * 1998-04-17 1999-10-28 Kyowa Hakko Kogyo Co., Ltd. Agent analgesique
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US7521456B2 (en) 1998-04-29 2009-04-21 Osi Pharmaceuticals, Inc. N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
US6900221B1 (en) 1999-11-11 2005-05-31 Osi Pharmaceuticals, Inc. Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride

Also Published As

Publication number Publication date
DE69519469D1 (de) 2000-12-28
NO961601D0 (no) 1996-04-22
CA2174854C (en) 2001-11-20
EP0726267B1 (en) 2000-11-22
CN1134150A (zh) 1996-10-23
NO310658B1 (no) 2001-08-06
ES2153491T3 (es) 2001-03-01
NZ291506A (en) 1997-03-24
CA2174854A1 (en) 1996-03-07
KR960705810A (ko) 1996-11-08
AU3265595A (en) 1996-03-22
EP0726267A1 (en) 1996-08-14
DE69519469T2 (de) 2001-07-26
US5948784A (en) 1999-09-07
CN1043991C (zh) 1999-07-07
EP0726267A4 (en) 1996-12-11
ATE197710T1 (de) 2000-12-15
FI961758A (fi) 1996-04-24
NO961601L (no) 1996-04-22
FI961758A0 (fi) 1996-04-24
AU689304B2 (en) 1998-03-26
WO1996006841A1 (fr) 1996-03-07

Similar Documents

Publication Publication Date Title
JPH09165385A (ja) キナゾリン誘導体
US5624926A (en) Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
US6794382B2 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
EP1566380B1 (en) Isoquinoline compounds and medicinal use thereof
US20070161620A1 (en) Isoquinoline compound and pharmaceutical use thereof
JP2544939B2 (ja) ベンゾヘテロ環誘導体
WO1999053924A1 (fr) Agent analgesique
JPH08151377A (ja) キナゾリン誘導体
JP2529082B2 (ja) 新規なエリプチシン化合物、それら化合物の製造法及びそれら化合物を含有する製剤組成物
JP2519734B2 (ja) 新規置換ピリド〔2,3−b〕〔1,4〕ベンゾジアゼピン−6−オン,その製法及びその化合物を含む医薬
PL114573B1 (en) Process for preparing novel,substituted in position 11,5,11-dihydro-6h-pyrido/2,3-b//1,4/-benzodiazepin-6-ones
IE852403L (en) 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones
EP0551527B1 (en) Pyrroloazepine derivative
NZ226681A (en) Diazepinone derivatives: preparatory processes and pharmaceutical compositions
JP2810795B2 (ja) キナゾリン誘導体
EP0919233B1 (en) Therapeutic agent for kidney diseases
JP3229693B2 (ja) ピペラジン誘導体
WO1999019326A1 (fr) Derives de piperidine
JP2002047287A (ja) 芳香族誘導体
IE67060B1 (en) New pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them
WO1998033792A1 (fr) Derives de la piperidine
JPH0827149A (ja) ピリミジノン誘導体およびその塩